Development and validation of a multimodal MRI habitat-based deep learning fusion model for predicting 252Cf neutron therapy response in cervical cancer

Figure 2 Kaplan-Meier survival curves for different fusion model prediction groups. High benefit group (n = 21, red line) vs low benefit group (n = 9, gray dashed line). A: Progression-free survival (PFS): 3-year PFS 85.7% vs 44.4% (P = 0.008); B: Overall survival (OS): 3-year OS 92.5% vs 71.4% (P = 0.003).